Project information

Cancer and Dementia Research Imaging Centre

Large scanners called MRI (Magnetic Resonance Imaging) have revolutionised the detection and treatment of diseases including cancer and dementia. Cobalt will create a state-of-the-art MRI facility for research working with the Institute of Translational Medicine.

January 2017 - January 2022

Charity information: Cobalt

Cobalt logo
  • Need

    Need

    MRI capacity to undertake research is severely restricted which greatly impedes the progress of research projects. Cobalt has been working with the Institute of Translational Medicine (ITM) to develop an MRI facility for research to improve patient diagnosis and treatments. The ITM has been established by a strategic alliance between the University of Birmingham, Birmingham Children’s Hospital, Birmingham Women’s Hospital, and the University Hospitals Birmingham NHS Foundation Trust.

    Solution

    There is a need for MRI scanners for research. This will cost £1.4m for the equipment and a purpose designed building at a cost of £600,000. This service will utilise the very latest technology in order to support a wide range of research including cardiac, liver, oncology and neurosurgery. The facility will enable vital research to be undertaken and introduce the latest imaging techniques to benefit many patients.

  • Aims

    Aim 1

    To create a state-of-the-art MRI research facility for the benefit of many patients

    Activities

    » The MRI scanner will be of a very high specification providing the very latest imaging techniques.
    » Research into methods of detection, diagnosis, treatment and prevention of disease will be published.
    » To harness research strengths in the University and NHS to deliver better treatments and care to patients.
    » The MRI research facility will be supported by the MRI scanner manufacturer Siemens to introduce new research methods.

    We will measure the number of research studies accommodated by the MRI research facility and the number of research papers published.


    Aim 2

    To accelerate research outcomes to improve patient treatment and care, 'translational medicine'.

    Activities

    » The MRI facility will be located adjacent to the ITM allowing good access for patients.
    » The ITM is a strategic alliance between University Hospitals Birmingham, University of Birmingham and Birmingham Children’s Hospital.
    » Leading clinicians will support the research MRI facility.

    Identifying new techniques that can benefit disease diagnosis and treatment and by measuring the timeline between the research and the use of the technique in clinical practice.


    Aim 3

    To support collaborative networks and partnerships to benefit MRI research.

    Activities

    » The Queen Elizabeth Hospital is recognised as one of the leading hospitals in Europe.
    » The ITM has been established by a strategic alliance between the University of Birmingham and 3 NHS Trusts.
    » The MRI facility will be run by Cobalt working with staff from the QE Hospital

    Engagement with all partners, and effective partnership working to ensure the development of new research MRI techniques.


    Aim 4

    To harness research strengths in to deliver better patient treatments and care.

    Activities

    » We will take part in research projects across abroad spectrum of diseases.
    » We will work in partnership with all stakeholders to develop, deliver and then publish the results of research projects.
    » The centre will bring together leading clinicians from all disciplines through the ITM.

    We will demonstrate research to clinical practice (bench to bedside) and publish details of the number of successful research projects. We will work in partnership.


  • Impact

    Impact

    The development of MRI scanning has revolutionised the detection and informed treatment of a wide range of diseases.

    For the first time clinicians and researchers from a number of partner organisations will have access to state-of-the art MRI research facilities. The MRI technology will be continually upgraded in order to deliver the very best research technology.

    The success will be based on the number of successful research projects and how research improves patients care and treatment.

    Risk

    Underutilisation of the MRI scanner for research initially, any space capacity MRI capacity will be used for routine clinical patient to support the QE Hospital.

    Changes in MRI technology - Siemens, the MRI scanner manufacturer will upgrade the MRI scanner, provide the very latest imaging techniques.

    Using the latest MRI technology - the facility will be staffed jointly by experienced staff from the QE Hospital and Cobalt. Siemens will also provide clinical scientists and specialists.

    Reporting

    Donors will receive regular updates on the project. This will include but will not be limited to:

    • The number of type of research undertaken
    • The number of patients scanned
    • The number of papers published
    • Techniques introduced into clinical practice as a result of the facility

  • Budget

    Budget - Project Cost: £2,000,000

    Loading graph....
      Amount Heading Description
      £1,400,000 MRI Scanner State of the art 3.0 Tesla MRI scanner
      £600,000 Building High Tech modular building for the imaging centre

    Current Funding / Pledges

    Source Amount
    Cobalt £1,000,000 Guaranteed
    Charitable Trust £250,000 Guaranteed
  • Background

    Location

    The project will be located next to the Institute of Translational Medicine at the Queen Elizabeth Hospital. The ITM has been developed by Birmingham Health Partners, a strategic alliance between University Hospitals Birmingham NHS Foundation Trust, University of Birmingham and Birmingham Children’s Hospital NHS Foundation Trust to maximise facilities, expertise and access to patients and deliver major advances in healthcare.

    Beneficiaries

    It is expected that over 10,000 patients each year will be scanned within the facility. The facility will enable clinicians and researchers from 3 NHS Trust and the University to have access to MRI for the first to enable a number of research projects. The support from Siemens, the MRI manufacturer, will enable clinicians to introduce new imaging techniques into clinical practice for the benefit of the patient.

  • Why Us?

    Why Us?

    Cobalt is a leading medical imaging charity established over 50 years ago. The Charity works with the NHS to provide state of the art diagnostic imaging scanning over 50,000 each year using the latest MRI technology. Cobalt also supports and participates in research and delivers education to healthcare professionals on a national and international basis. The Charity has the experience, expertise and relationships to make his project work.

    Read more about the Charity running this project.

    People

    Professor Iain Lyburn

    Cobalt Medical Director and a Consultant Radiologist with Gloucestershire Hospitals NHS Trust.

    Dr Vijay Sawlani

    Consultant Neuroradiologist and Hon. Senior Lecturer, School of Cancer Sciences University Hospitals Birmingham NHS Foundation Trust.

    Mr Antonio Belli MD, FRCS, FRCS

    Professor of Trauma Neurosurgery Institute of Inflammation & Ageing at the QE Hospital. Advisor NICE.

    Mr Peter Sharpe BSc DCR FBIR

    Chief Executive Cobalt and Project Manager.

For the first time clinicians and researchers will have access to state-of-the art MRI facilities for research to improve patient care across a broad range of conditions.

Professor Stuart Green